The relationship of the COVID-19 pandemic with thrombosis caused diseases (pulmonary embolism, ischemic stroke, myocardial infarction, deep vein thrombosis)

A new type of coronavirus that emerged in Wuhan, China in late 2019 has led to the COVID-19 pandemic. Millions of people have been infected, but various complications have arisen. Apart from severe respiratory failure, another important life-threatening complication is venous thromboembolic events. There are various literature studies related to this. In this study, those who had thromboembolic events under the headings of deep vein thrombosis, pulmonary thromboembolism, acute coronary syndrome and cerebrovascular disease of the patients who applied to our emergency medicine clinic in the one-year periods before and after the pandemic were examined and the statistical differences between the two periods were examined. Age, gender, diagnosis of thromboembolism, laboratory and radiological data, consultation notes of patients who applied to Gaziantep University Emergency Medicine Clinic in the one-year period before and after the pandemic were retrospectively analyzed. Data were collected and statistical analyzes were made with SPSS 22.0 and MedCalc program. The study was conducted with a total of 1733 patients, 853 of whom met the inclusion criteria before the pandemic and 880 after the pandemic. It was determined that thromboembolic events increased in the post-COVID period and the number of patients admitted under each thromboembolic heading increased statistically. This study shows an increase in thromboembolic events with the COVID pandemic. The findings obtained may help clinicians be more careful about this issue and contribute to the regulation of treatment protocols. KEYWORDS: COVID-19; Venous thromboembolism; Emergency Medicine